257 related articles for article (PubMed ID: 22932947)
1. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.
Vita R; Saraceno G; Trimarchi F; Benvenga S
Endocrine; 2013 Feb; 43(1):154-60. PubMed ID: 22932947
[TBL] [Abstract][Full Text] [Related]
2. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
3. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
[TBL] [Abstract][Full Text] [Related]
4. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
5. The administration of L-thyroxine as soft gel capsule or liquid solution.
Vita R; Fallahi P; Antonelli A; Benvenga S
Expert Opin Drug Deliv; 2014 Jul; 11(7):1103-11. PubMed ID: 24896369
[TBL] [Abstract][Full Text] [Related]
6. In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E; Catalano A; Lasco A; Morabito N; Benvenga S
Endocrine; 2019 Sep; 65(3):569-579. PubMed ID: 30919287
[TBL] [Abstract][Full Text] [Related]
7. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
8. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
9. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
10. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
11. L-T4 Therapy in Enteric Malabsorptive Disorders.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
[TBL] [Abstract][Full Text] [Related]
12. Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.
Ribichini D; Fiorini G; Repaci A; Castelli V; Gatta L; Vaira D; Pasquali R
Endocrine; 2017 Sep; 57(3):394-401. PubMed ID: 27848196
[TBL] [Abstract][Full Text] [Related]
13. Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule.
Vita R; Benvenga S
Endocr Pract; 2014 Mar; 20(3):e38-41. PubMed ID: 24246350
[TBL] [Abstract][Full Text] [Related]
14. Altered intestinal absorption of L-thyroxine caused by coffee.
Benvenga S; Bartolone L; Pappalardo MA; Russo A; Lapa D; Giorgianni G; Saraceno G; Trimarchi F
Thyroid; 2008 Mar; 18(3):293-301. PubMed ID: 18341376
[TBL] [Abstract][Full Text] [Related]
15. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
16. Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.
Benvenga S
J Clin Transl Endocrinol; 2019 Dec; 18():100204. PubMed ID: 31844631
[TBL] [Abstract][Full Text] [Related]
17. Lactose intolerance and levothyroxine malabsorption: a review of the literature and report of a series of patients treated with liquid L-T4 without lactose.
Ferrari SM; Patrizio A; Mazzi V; Ragusa F; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Bracchitta F; Stoppini G; Frenzilli G; Baldini E; Virili C; Benvenga S; Fallahi P; Antonelli A
Front Endocrinol (Lausanne); 2024; 15():1386510. PubMed ID: 38665263
[TBL] [Abstract][Full Text] [Related]
18. Thyroxine softgel capsule in patients with gastric-related T4 malabsorption.
Santaguida MG; Virili C; Del Duca SC; Cellini M; Gatto I; Brusca N; De Vito C; Gargano L; Centanni M
Endocrine; 2015 May; 49(1):51-7. PubMed ID: 25595886
[TBL] [Abstract][Full Text] [Related]
19. Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis.
Jubiz W; Ramirez M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1031-4. PubMed ID: 24601693
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
